Melatonin, a calpain inhibitor in the central nervous system: Current status and future perspectives

J Cell Physiol. 2019 Feb;234(2):1001-1007. doi: 10.1002/jcp.27084. Epub 2018 Aug 26.

Abstract

Dysregulation of neuronal Ca2+ and oxidative stress plays an important role in the activation of cysteine proteases including calpains and caspases that contribute to neuronal death. In neurodegenerative diseases, traumatic brain injury, stroke, and neuropathic pain calpain activities are markedly increased. Melatonin is a beneficial supplement in the treatment of central nervous system (CNS) disorders. Melatonin is a potent antioxidant and works as a free-radical scavenger to regulate a large number of molecular pathways, including oxidative stress, inflammation, apoptosis, and cell death under different pathological conditions. However, limited studies have evaluated the inhibitory effect of melatonin on calpains. This review summarizes the current knowledge related to the effects of melatonin on calpains in some of the common CNS disorders.

Keywords: calpain; central nervous system; melatonin.

Publication types

  • Review

MeSH terms

  • Animals
  • Calpain / antagonists & inhibitors*
  • Calpain / metabolism
  • Central Nervous System / drug effects*
  • Central Nervous System / enzymology
  • Central Nervous System / pathology
  • Central Nervous System / physiopathology
  • Central Nervous System Diseases / drug therapy*
  • Central Nervous System Diseases / enzymology
  • Central Nervous System Diseases / pathology
  • Central Nervous System Diseases / physiopathology
  • Cysteine Proteinase Inhibitors / therapeutic use*
  • Humans
  • Melatonin / therapeutic use*
  • Signal Transduction

Substances

  • Cysteine Proteinase Inhibitors
  • Calpain
  • Melatonin